MedChem 2018

New Avenues in Kinase Drug Discovery: a Bright Future ?

Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV

 Namur, Belgium    November 23, 2018

Invited Lectures

Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptors

Dr Patrick ANGIBAUD
Dr Patrick ANGIBAUD
JANSSEN R&D, Val de Reuil, France
Read more

Chemoinformatics-Driven View of Kinase Drug Discovery (Lecture sponsored by ChemMedChem)

Prof. Jürgen BAJORATH
Prof. Jürgen BAJORATH
UNIVERSITY OF BONN, Bonn, Germany
Read more

Kinase Inhibitors for Non-oncological Indications: Is there a Future ?

Dr Doriano FABBRO
Dr Doriano FABBRO
PIQUR THERAPEUTICS, Basel , Switzerland
Read more

CDK8 Inhibitors with Pre-Engineered Long Residence Time: From Design to Tumor Xenograft Models

Dr Koen HEKKING
Dr Koen HEKKING
MERCACHEM-SYNCOM, Nijmegen, The Netherlands
Read more

Lead Optimization as a Playground for New Concepts, Reactions and Chemical Modalities: Development of Several Generations of Clinical CDK Inhibitors at Bayer AG

Dr Ulrich LÜCKING
Dr Ulrich LÜCKING
BAYER HEALTHCARE, Berlin, Germany
Read more

Discovery, Development and In Vivo Profiling of a Novel Class of Immunosuppressive PI4KIIIβ Lipid Kinase Inhibitors

Dr James REUBERSON
Dr James REUBERSON
UCB, Slough, United Kingdom
Read more

Oral Communications

OC02 - Discovery And Development Of Highly Potent And Selective FLT3 Kinase Inhibitors, A New Class of Peripheral Drugs for Treating Neuropathic Pain

Dr Claire AMIABLE
Dr Claire AMIABLE
BCI PHARMA, Montpellier, France
Read more

OC01 - A Fast in Silico Fragment-Based Design Tool for the Discovery of Novel Kinase Inhibitors

Prof. Pascal BONNET
Prof. Pascal BONNET
UNIVERSITY OF ORLÉANS, Orléans, France
Read more

OC03 - Imidazo[4,5-B]Pyridine Derivatives as Potent Tam Inhibitors: From Synthesis To Cellular Imaging

Dr Sandrine PIGUEL
Dr Sandrine PIGUEL
INSTITUT CURIE, Orsay, France
Read more